Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Psychopharmacology for Dermatologists
Description
In this presentation on psychopharmacology for dermatologists, the speaker highlights the importance of incorporating psychotropic medications into dermatological practice to better assist patients dealing with conditions like anxiety, depression, and OCD. Despite dermatology's hesitance to engage with psychopharmacology, the speaker assures that it is both legal and ethical to prescribe these medications and emphasizes the common practice among non-psychiatrists who often lead in prescriptions of such agents. The talk covers various medication categories including anti-anxiety agents, antipsychotics, and antidepressants, focusing specifically on benzodiazepines like Alprazolam and alternatives like Buspirone for chronic cases. The speaker promotes a titration approach when prescribing—starting with lower doses and gradually increasing—to ensure patient safety and comfort. Additionally, discussions on effective medications include Doxepin for its dual role as an antidepressant and anti-itch agent, and Paroxetine for treating anxiety and OCD with specific dosing strategies. The overall message encourages dermatologists to become confident in prescribing these medications, asserting that doing so can significantly enhance the patient care experience without the need to refer patients to mental health professionals. The speaker concludes by reiterating the essence of titration to manage anxiety and improve therapeutic outcomes.
View moreConclusions
- Dermatologists can legally and ethically prescribe psychopharmacological agents for their patients.
- It is essential for dermatologists to become comfortable using medications from categories like antianxiety, antipsychotic, antidepressant, and anti-OCD.
- Titration is key; starting with lower doses and gradually increasing helps manage patient safety and comfort.
- Benzodiazepines are suitable for acute anxiety but should not be used long-term due to addiction risks; alternatives should be considered if anxiety persists.
- Buspirone is a non-addictive, non-sedating option for chronic anxiety, though it takes longer to feel its effects.
- Doxepin can serve dual purposes as both an antidepressant and an anti-anxiety agent, particularly at low doses.
- Paroxetine is effective for anxiety, depression, and OCD, but requires careful titration to avoid side effects.
- Patients often prefer medications like pimozide or hydroxyzine due to their reduced stigma and perceived safety.
- Dermatologists should increase awareness and education regarding the integration of psychopharmacology into dermatological practice to improve patient outcomes.
- Myers, B., Reddy, V., Chan, S., Thibodeaux, Q., Brownstone, N., & Koo, J. (2022). Optimizing doxepin therapy in dermatology: introducing blood level monitoring and genotype testing. The Journal of dermatological treatment, 33(1), 87-93. https://doi.org/10.1080/09546634.2020.1762841